reports
- Ahmed Ben Salem
PUB PUBLICIS GROUPE SA
FRA FRAPORT AG
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
APAML APERAM SA
GAMA GAMMA COMMUNICATIONS
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
RBT ROBERTET SA
ENI ENI S.P.A.
ALB CORPORACION FINANCIERA ALBA S.A.
ERA ERAMET SA
WPP WPP PLC
REP REPSOL SA
BP. BP P.L.C.
RBO ROCHE BOBOIS INTERNATIONAL SAS
TE TECHNIP ENERGIES NV
FORSE FORSEE POWER SA
SHEL SHELL PLC
HAVAS HAVAS N.V
- Ahmed Ben Salem
- Ahmed Ben Salem
- Ahmed Ben Salem
PUB PUBLICIS GROUPE SA
FRA FRAPORT AG
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
APAML APERAM SA
GAMA GAMMA COMMUNICATIONS
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
RBT ROBERTET SA
ENI ENI S.P.A.
ALB CORPORACION FINANCIERA ALBA S.A.
ERA ERAMET SA
WPP WPP PLC
REP REPSOL SA
BP. BP P.L.C.
RBO ROCHE BOBOIS INTERNATIONAL SAS
TE TECHNIP ENERGIES NV
FORSE FORSEE POWER SA
SHEL SHELL PLC
HAVAS HAVAS N.V
- Jerôme Bodin
- Jerôme Bodin
- Jerôme Bodin
Publicis : Publicis in 10 key questions (Outperform vs Neutral)
Our analysis of the top 10 questions about Publicis strengthens our positive view of Publicis' short term and long-term growth model. More favourable short-term momentum (H2 25 and 2026) and a more attractive valuation offer an opportunity to be positioned on a quality stock amid consolidation in the agency market. We are adopting an Outperform rating vs Neutral with a new target price of € 110 (vs € 100).
- Jerôme Bodin
Publicis : Publicis en 10 questions clefs (opinion Surperformance vs N...
Notre analyse à travers les 10 principales questions sur Publicis renforce notre vue positive sur le modèle de croissance de Publicis tant à court et long terme. Le momentum CT plus favorable (S2 25 et 2026) ainsi qu’une valorisation plus attractive offrent une opportunité de se positionner sur une valeur de qualité dans un contexte de consolidation du marché des agences. Nous adoptons une opinion Surperformance vs Neutre avec un nouvel objectif de cours de 110 € (vs 100 €).
- Robert Jan Vos
- Usama Tariq
- Robert Jan Vos
- Usama Tariq
BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Fun...
BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Funding and Global Support MELBOURNE, Australia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- BHP Xplor, the nine-month accelerator program aimed at transforming the discovery of critical minerals, has officially opened applications for the 2026 cohort. Following the success of the 2023, 2024, and 2025 cohorts, BHP Xplor invites early-stage explorers to apply for its next intake. The program is looking for ambitious teams and individuals dedicated to uncovering new sources of critical minerals essential for a sustainable future. ...
- Martin Marandon-Carlhian
- Oliver Metzger
- Sinan Doganli
- Stephane Houri
FME FRESENIUS MEDICAL CARE AG
VIE VEOLIA ENVIRONNEMENT SA
ENGI ENGIE SA.
KPN ROYAL KPN NV
ROG ROCHE HOLDING LTD
CBK COMMERZBANK AG
NOVN NOVARTIS AG
EVT EVOTEC SE
EN BOUYGUES SA
HNR1 HANNOVER RUECK SE
AFX CARL ZEISS MEDITEC AG
SRT3 SARTORIUS AG PREF
GLJ GRENKE AG
UTDI UNITED INTERNET AG
ELG ELMOS SEMICONDUCTOR SE
SDF K+S AG
ZAL ZALANDO SE
BAS BASF SE
SAN SANOFI
FRE FRESENIUS SE & CO. KGAA
BAYN BAYER AG
DTE DEUTSCHE TELEKOM AG
TLX TALANX AG
IMPN IMPLENIA AG
AIXA AIXTRON SE
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BC8 BECHTLE AG
ADN1 ADESSO AG
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
WAF SILTRONIC AG
SMHN SUESS MICROTEC AG
FNTN FREENET AG
AZN ASTRAZENECA PLC
BIM BIOMERIEUX SA
DUE DURR AG
BFSA BEFESA SA
SANT S&T AG
AEIN ALLGEIER HOLDING AG
HAG HENSOLDT AG
NA9 NAGARRO
FPE3 FUCHS PETROLUB SE
SPAC 468 SPAC I SE
GSK GSK PLC
IOS IONOS GROUP SE
NOVO B NOVO NORDISK A/S
SCHOTT PHARMA AG
CVC CVC CAPITAL PARTNERS PLC
- Martin Marandon-Carlhian
- Oliver Metzger
- Sinan Doganli
- Stephane Houri
FME FRESENIUS MEDICAL CARE AG
VIE VEOLIA ENVIRONNEMENT SA
ENGI ENGIE SA.
KPN ROYAL KPN NV
ROG ROCHE HOLDING LTD
CBK COMMERZBANK AG
NOVN NOVARTIS AG
EVT EVOTEC SE
EN BOUYGUES SA
HNR1 HANNOVER RUECK SE
AFX CARL ZEISS MEDITEC AG
SRT3 SARTORIUS AG PREF
GLJ GRENKE AG
UTDI UNITED INTERNET AG
ELG ELMOS SEMICONDUCTOR SE
SDF K+S AG
ZAL ZALANDO SE
BAS BASF SE
SAN SANOFI
FRE FRESENIUS SE & CO. KGAA
BAYN BAYER AG
DTE DEUTSCHE TELEKOM AG
TLX TALANX AG
IMPN IMPLENIA AG
AIXA AIXTRON SE
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BC8 BECHTLE AG
ADN1 ADESSO AG
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
WAF SILTRONIC AG
SMHN SUESS MICROTEC AG
FNTN FREENET AG
AZN ASTRAZENECA PLC
BIM BIOMERIEUX SA
DUE DURR AG
BFSA BEFESA SA
SANT S&T AG
AEIN ALLGEIER HOLDING AG
HAG HENSOLDT AG
NA9 NAGARRO
FPE3 FUCHS PETROLUB SE
SPAC 468 SPAC I SE
GSK GSK PLC
IOS IONOS GROUP SE
NOVO B NOVO NORDISK A/S
SCHOTT PHARMA AG
- Louis Boujard
- CFA
- Philippe Ourpatian
- Louis Boujard
- CFA
- Philippe Ourpatian
- Carole Braudeau
- Carole Braudeau
- Maxime Kogge
- Maxime Kogge
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.